维普中文期刊产品整合服务
53篇 您的检索式:作者名="Atagi S"
    题名 作者 年代 出处 被引量
1High-resolution CT findings of diffuse bronchioloalveolar carcinoma in 38 patients显示文摘 Atagi S Kawahara M 1999AJR1999,173,6:1
2Pulmonary hyalinizing granuloma with Castleman's disease显示文摘Atagi S Sakatani M Akira M 1994Intern Med1994,33,11:1
3Specific induction of metallothionein synthesis by mitochondrial oxidative stress显示文摘Kondoh M Inoue Y Atagi S 2001Life Sciences2001,69,:1
4LUX-Lung 4 : a phase II trial of afatinib in patients with advanced non-small-cell lung cancer who progressed during prior treatment with erlotinib, gefiinib, or both 显示文摘Katakami N Atagi S Goto K 2013J Clin Oneol2013,31,27:1
5Specific induction metallothinonein synthesis by chondrial oxidative stress显示文摘KONDON M INOUE Y ATAGI S 2001Life Sci2001,69,18:1
6High-resolution CT findings of diffuse bronchioloalveolar carcinoma in 38 patients显示文摘Akira M Atagi S Kawahara M 1999AJR1999,173,6:1
7Standard thoracil radiortheraqy with or without concurrent daily low-dose camoplatin in elderly patients with locally advanced non-smell lung a phase 3 trial of The Japan Clinical Oncology Group(JCOG 9812)显示文摘Atagis S Kawaham M Tamum T 2005Jpn J Clin Oncol2005,35,4:1
8A phase II trial of afatinib ( BIBW 2992) in patients ( pts ) with advanced non-small cell lung cancer previously treated with erlotinib ( E) or gefitinib (G)显示文摘Yamamoto N Katakami N Atagi S 2011J Clin Oncol2011,,:1
9LUX-Lung 4 : Aphase II trial of afatinib in patients with advanced non-small-cell lung cancer who progressed during prior treat-ment with erlotinib, gefitinib, or both 显示文摘Katakami N Atagi S Goto K 2013J Clin Oncol2013,31,27:1
10Erlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harbouring EGFR mutations(JO25567):an open-label,randomised,multicentre,phase 2 study显示文摘Seto T Kato T Nishio M Goto K Atagi S Hosomi Y 2014Lancet Oncol2014,15,11:1
11High-resolution CT findings of diffuse bronchioloalveolar carcinoma in 38 patients显示文摘Akira M Atagi S Kawahara M 1999AJR Am J Roentgenol1999,173,:1
12Standard thoracic radio- therapy with or without concurrent daily low-dose carboplatin in elderly patients with locally advanced nonsmall cell lung cancer: a phase Ⅲ trial of the Japan Clinical Oncology Group (JCOG9812) 显示文摘Atagi S Kawahara M Tamura T 2005Jpn J Clin Oncol2005,35,:1
13Lux-Lung 4:a phase Ⅱ tri-al of afatinib in patients with advanced non-small-cell lung cancer who progressed during prior treatment with erlotinib,gefitinib,or both显示文摘Katakami N Atagi S Goto K 2013J ClinOncol2013,31,27:1
14High-resolution CT findings of diffuse bronchioloalveolar carcinoma in 38 pa- tients显示文摘Akira M Atagi S Kawahara M 1999AJR1999,173,6:1
15Specific induction of metallothionein synthesis by mitochondrial oxidative stress显示文摘Kondoh M Inoue Y Atagi S 2001Life Sci2001,69,:1
16A phase II study of continuous concurrent thoracic radiotherapy in combination with mitomycin, vindesine and cisplatin in unresectable stage Ⅲ non-small cell lung cancer显示文摘Atagi S Kawahara M Hosoe S 2002Lung Cancer2002,36,1:1
17High-resolution CT findings of diffuse bronchioloalveolar carcinoma in 38 patients显示文摘Akira M Atagi S Kawwhara M 1999AJR1999,173,:1
18High-Resolution CT Findings of Diffuse Bronchioloalveolar Carcinoma in 38 Patients 显示文摘AkiraM Atagi S Kawahara M 1999AJR1999,173,6:1
19A phase Ⅱ trial of afatinib (BIBW 2992) in patients (pts) with advanced non-small cell lung cancer previously treated with erlotinib (E) or gefitinib (G)显示文摘Yamamoto N Katakami N Atagi S 0,,:1
20LUX-Lung 4: a phase I/ trial of afatinib in patients with advanced non- small-cell lung cancer who progressed during prior treat- ment with erlotinib, gefitinib, or both 显示文摘Katakami N Atagi S Goto K 2013J Clin On- col2013,31,27:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费